Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
JCI Insight|December 12, 2022
The HIF-prolyl hydroxylases have distinct and nonredundant roles in colitis-associated cancerKilian B Kennel, Julius Burmeister, Praveen Radhakrishnan, et al.
Scientific Reports|October 15, 2017
Pharmacological HIF-inhibition attenuates postoperative adhesion formationMoritz J Strowitzki, Alina S Ritter, Praveen Radhakrishnan, et al.
Annals of Surgery|March 8, 2017
Prolyl Hydroxylase Inhibition Enhances Liver Regeneration Without Induction of Tumor GrowthJonathan M Harnoss, Lisa K Platzer, Juergen Burhenne, et al.
Annals of Surgical Oncology|March 26, 2026
Noninvasive Tests for Liver Fibrosis Predict Postoperative Complications After Resection of Colorectal Liver MetastasesChristopher Tuffs, Oliver Marg, Daniar Amin, et al.
Coronary Artery Disease|October 31, 2017
Insights into coronary collateral formation from a novel porcine semiacute infarction modelFlorian Krackhardt, Jonathan M Harnoss, Matthias W Waliszewski, et al.
Inflammatory Bowel Diseases|October 17, 2019
Prolyl Hydroxylase Inhibition Mitigates PouchitisJonathan M Harnoss, Jasper M Gebhardt, Praveen Radhakrishnan, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|October 30, 2016
Hydroxylase inhibition regulates inflammation-induced intestinal fibrosis through the suppression of ERK-mediated TGF-β1 signaling. [corrected]Mario C Manresa, Murtaza M Tambuwala, Praveen Radhakrishnan, et al.
The Journal of Cell Biology|April 21, 2022
Antigen-derived peptides engage the ER stress sensor IRE1α to curb dendritic cell cross-presentationOfer Guttman, Adrien Le Thomas, Scot Marsters, et al.
Cancer Research|February 28, 2016
Prolyl Hydroxylase 3 Attenuates MCL-1-Mediated ATP Production to Suppress the Metastatic Potential of Colorectal Cancer CellsPraveenkumar Radhakrishnan, Nadine Ruh, Jonathan M Harnoss, et al.
Pageof 4